# Artivion Reports Fourth Quarter and Full Year 2025 Financial Results
Canonical URL: https://biopharmsignal.com/news/AORT/artivion-reports-fourth-quarter-and-full-year-2025-financial-results
Ticker: AORT
Company: Artivion
Source: Artivion
Published: 2026-02-12 21:05 EST
Original Source URL: https://investors.artivion.com
## Summary

Fourth Quarter Highlights: GAAP revenue was $116.0 million in the fourth quarter of 2025 versus $97.3 million in the fourth quarter of 2024. For the full year, GAAP revenue was $441.3 million versus $388.5 million for the full year of 2024. GAAP net income was $2.4 million, or $0.05 per fully

## Article Body
Fourth Quarter Highlights: GAAP revenue was $116.0 million in the fourth quarter of 2025 versus $97.3 million in the fourth quarter of 2024. For the full year, GAAP revenue was $441.3 million versus $388.5 million for the full year of 2024. GAAP net income was $2.4 million, or $0.05 per fully
## Recent Company News
- 2026-05-18 11:00 EST — [Artivion Completes Acquisition of Endospan Ltd.](https://biopharmsignal.com/news/AORT/artivion-completes-acquisition-of-endospan-ltd) — Source: Artivion
- 2026-05-07 20:05 EST — [Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan](https://biopharmsignal.com/news/AORT/artivion-reports-first-quarter-2026-financial-results-and-announces-exercise-of-option-to-acquire-endospan) — Source: Artivion
- 2026-04-23 20:15 EST — [Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results](https://biopharmsignal.com/news/AORT/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2026-financial-results) — Source: Artivion
- 2026-04-07 11:00 EST — [Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System](https://biopharmsignal.com/news/AORT/artivion-announces-u-s-fda-approval-of-the-nexusr-aortic-arch-system) — Source: Artivion
- 2026-03-03 21:10 EST — [Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference](https://biopharmsignal.com/news/AORT/artivion-to-participate-in-the-oppenheimer-36th-annual-healthcare-medtech-and-services-conference) — Source: Artivion
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)